Ocuphire
Tuesday, February 27, 2024
Plymouth
Ophthalmology
Ocuphire Pharma is a late clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of retinal and refractive eye disorders.
Speakers
State
MI
Country
United States
Website
https://www.ocuphire.com/
CEO/Top Company Official
George Magrath
Lead Product in Development
APX3330
Development Phase of Primary Product
Phase III
Number Of Unlicensed Products
1